Julia M. Bainbridge;Felix Funk;Peter O. Geisser;Mark Slack;Stephen M. Courtney;Stefan Jaeger;Tara Davenport;Susanna Burckhardt;Wilm Buhr;Vincent A. Corden;Franz Dürrenberger;Christophe;Mark P. Ridgill
发明人:
Franz Dürrenberger,Susanna Burckhardt,Peter O. Geisser,Wilm Buhr,Felix Funk,Julia M. Bainbridge,Vincent A. Corden,Stephen M. Courtney,Tara Davenport,Stefan Jaeger,Mark P. Ridgill,Mark Slack,Christophe
申请号：
US13391712
公开号：
US20120202806A1
申请日:
2010.08.31
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention relates to new hepcidin antagonists, pharmaceutical compositions containing them and the use thereof as a drug, in particular for the treatment of iron metabolism disorders such as, in particular, iron deficiency diseases and anaemia, in particular anaemia associated with chronic inflammatory disease (ACD: anaemia of chronic disease and AI: anaemia of inflammation).
